Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

241.46B

Market cap241.46B

Price-Earnings ratio

15.19

Price-Earnings ratio15.19

Dividend yield

2.23%

Dividend yield2.23%

Average volume

11.74M

Average volume11.74M

High today

$55.10

High today$55.10

Low today

$54.09

Low today$54.09

Open price

$54.36

Open price$54.36

Volume

12.99M

Volume12.99M

52 Week high

$138.22

52 Week high$138.22

52 Week low

$45.05

52 Week low$45.05

NVO News

Benzinga 13h

Ozempic Is The New Botox - And Novo, Eli Lilly Are Printing Billions - Novo Nordisk, Eli Lilly - Benzinga

...

Benzinga 13h

Ozempic Is The New Botox And Big Pharma Is Printing Billions

Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S NVO and Eli Lilly And Co LLY achieve a combined m...

Benzinga 5d

After Copycat Boom, China's Drugmakers Target Global Generics

China-based drugmakers that once fueled a surge of copycat weight-loss treatments in the U.S. are now pivoting to generics of Novo Nordisk‘s NVO Wegovy and Eli...

Analyst ratings

50%

of 32 ratings

Buy

46.9%

Hold

50%

Sell

3.1%

More NVO News

TipRanks 7d

Novo Nordisk Stock Jumps and Eli Lilly Falls on Positive Wegovy Data

Shares of Novo Nordisk (NVO) are up 1.6% in pre-market trading after the Danish drugmaker announced that its Wegovy weight-loss drug reduces the risk of heart a...